Heart Failure
The Heart Failure pipeline: 74 tracked drugs, 12 approved for this indication.
12 approved / phase 419 Phase 32 Phase 2/322 Phase 25 Phase 1/212 Phase 12 preclinical / unstaged
Compare the share prices of listed companies in Heart Failure →
Total attributable cost
$27.7B
$3,594/patient
Drug spend
Not yet sourced
All severities (2021-2023 NHANES cycle) · US
The Heart Failure pipeline
Key trial results for every approved and late-stage drug: Heart Failure results by drug.